Pfizer, BioNTech initial vaccine results impress, but scientists remain cautious


Modified 10 Nov 2020, 4:38 am

Scientists on Monday said initial trial results for Pfizer Inc and BioNTech's coronavirus vaccine far outpaced their expectations for protection against a completely new disease, but that many questions remain unanswered.

The drugmakers said their vaccine was more than 90 percent effective at preventing Covid-19, based on data from the first 94 people in the trial to become infected with the coronavirus...

All Access Plan
starting from


per month
Subscribe Now
You can cancel anytime.
Get unlimited access to our articles on web and apps
Add comments to our articles
Bookmark articles to read later
We accept
Student or Senior Citizen? Get a special rateGroup / Institutional / Corporate Plans
Already Subscribed?
Sign In